Will house 18 CGMP viral vector manufacturing suites designed to accommodate multiple bioreactors up to 2,000-liter scale and commercial manufacturing.
ten23 health’s new combination of pharma development services with clinical & commercial fill/finish services will offer customers an end-to-end capabilities.